Analysis of cyclin-dependent kinase 2-regulated phosphorylation of stathmin in etoposide-induced apoptotic HeLa cells by two-dimensional electrophoresis and mass spectrometry
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Y | - |
dc.contributor.author | Koo, KT | - |
dc.contributor.author | Choi, JS | - |
dc.contributor.author | Jin, YH | - |
dc.contributor.author | Yim, H | - |
dc.contributor.author | Oh, YT | - |
dc.contributor.author | Lee, SK | - |
dc.date.accessioned | 2021-06-23T23:39:31Z | - |
dc.date.available | 2021-06-23T23:39:31Z | - |
dc.date.issued | 2005-04 | - |
dc.identifier.issn | 1344-9702 | - |
dc.identifier.issn | 1347-5207 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/46039 | - |
dc.description.abstract | The candidate proteins that are involved in the cyclin-dependent kinase 2 (cdk2) signaling pathway were analyzed by comparing different proteins between dominant negative cdk2 overexpressed and control HeLa cells using two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). The 2-DE and MS indicated that stathmin and its monophosphorylated form were induced in etoposide-treated HeLa cells compared to untreated cells and this effect was inhibited by overexpression of dominant negative mutant form of cdk2. Further analysis showed that serine-25 (Ser-25), which comprises the conserved target motif for phosphorylation by mitogen-activated protein kinase (MAPK), was the major phosphorylation site of monophosphorylated form of stathmin. These findings indicate that etoposide-induced expression and phosphorylation at Ser-25 of stathmin might be mediated by activation of the MAPK signaling pathway, which is mediated by the cdk2 activation during the onset of the anticancer agent induced apoptotic events in the cancer cells. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.title | Analysis of cyclin-dependent kinase 2-regulated phosphorylation of stathmin in etoposide-induced apoptotic HeLa cells by two-dimensional electrophoresis and mass spectrometry | - |
dc.type | Article | - |
dc.publisher.location | 일본 | - |
dc.identifier.doi | 10.1248/jhs.51.224 | - |
dc.identifier.scopusid | 2-s2.0-18244375855 | - |
dc.identifier.wosid | 000228455500018 | - |
dc.identifier.bibliographicCitation | JOURNAL OF HEALTH SCIENCE, v.51, no.2, pp 224 - 232 | - |
dc.citation.title | JOURNAL OF HEALTH SCIENCE | - |
dc.citation.volume | 51 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 224 | - |
dc.citation.endPage | 232 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | ACTIVATED PROTEIN-KINASE | - |
dc.subject.keywordPlus | NEURON-ENRICHED PHOSPHOPROTEIN | - |
dc.subject.keywordPlus | HEAT-SHOCK | - |
dc.subject.keywordPlus | ONCOPROTEIN-18 | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | SERINE-25 | - |
dc.subject.keywordPlus | PATHWAYS | - |
dc.subject.keywordPlus | CLEAVAGE | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordAuthor | stathmin | - |
dc.subject.keywordAuthor | cyclin-dependent kinase 2 | - |
dc.subject.keywordAuthor | cancer cell | - |
dc.subject.keywordAuthor | etoposide | - |
dc.subject.keywordAuthor | proteomic analysis | - |
dc.identifier.url | https://www.jstage.jst.go.jp/article/jhs/51/2/51_2_224/_article | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.